XCNN-SC: Explainable CNN for SARS-CoV-2 variants classification and mutation detection.

Comput Biol Med

Biotechnology Department, Faculty of New Sciences and Technologies, Semnan University, Semnan, Iran. Electronic address:

Published: October 2023

AI Article Synopsis

  • The COVID-19 pandemic caused by SARS-CoV-2 led to millions of deaths and was complicated by the virus's rapid mutation, requiring effective variant identification and classification.
  • Researchers analyzed 82,802 whole genomes from various SARS-CoV-2 variants using a single-layer 1D-CNN model, achieving high accuracy and precision in classification.
  • The study also examined CNN feature maps, revealing significant mutations and their potential functional impacts, demonstrating the model’s ability to extract crucial features for understanding variant differences.

Article Abstract

The COVID-19 pandemic spread rapidly all over the world in 2019, causing the deaths of millions of people. One of the main challenges in controlling the pandemic was the high rate of virus mutation, which evaded the immune system and reduced the vaccine's effectiveness. Due to the differences in symptoms, transmission and mortality rate, and effective prevention strategies of each variant, identifying and classifying different variants is a great necessity. In the present study, 82802 whole genomes of Alpha, Beta, Delta, Eta, Epsilon, Lota, and Omicron variants of SARS-CoV-2 were obtained from the NCBI database. The label encoding method was applied to convert the genomic sequences to numeric sequences. Then, a single-layer 1D-CNN model was used to classify seven variants of SARS-CoV-2 and achieved 99.78% accuracy, 97.98% precision, 97.66% sensitivity, 99.95% specificity, and 98.68% F1-score. The max pool layer feature maps of this network were investigated to discover the sequence discriminative regions in SARS-CoV-2 variants and their effect on biological functional differences. The feature map examination led to the detection of three mutations; one of them was a missense mutation, which has been reported previously. The rest of the detected mutations were silent mutations. In conclusion, the achieved results indicated that CNN models can extract effective features to discriminate several SARS-CoV-2 variants. Also, investigation of CNN feature maps led to an explainable CNN revealing the learned knowledge of the network from the training database. This knowledge helped us to detect mutations and their functional effects in different variants.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2023.107606DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 variants
12
explainable cnn
8
variants sars-cov-2
8
feature maps
8
variants
7
sars-cov-2
5
xcnn-sc explainable
4
cnn
4
cnn sars-cov-2
4
variants classification
4

Similar Publications

Nonhuman primate antigenic cartography of SARS-CoV-2.

Cell Rep

January 2025

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address:

Virus neutralization profiles against primary infection sera and corresponding antigenic cartography are integral part of the COVID-19 and influenza vaccine strain selection processes. Human single variant exposure sera have previously defined the antigenic relationships among SARS-CoV-2 variants but are now largely unavailable due to widespread population immunity. Therefore, antigenic characterization of future SARS-CoV-2 variants will require an animal model, analogous to using ferrets for influenza virus.

View Article and Find Full Text PDF

SARS-CoV-2 variants are mainly defined by mutations in their spike. It is therefore critical to understand how the evolutionary trajectories of spike affect virus phenotypes. So far, it has been challenging to comprehensively compare the many spikes that emerged during the pandemic in a single experimental platform.

View Article and Find Full Text PDF

SARS-CoV-2 has continued spreading around the world in recent years since the initial outbreak in 2019, frequently developing into new variants with greater human infectious capacity. SARS-CoV-2 and its mutants use the angiotensin-converting enzyme 2 (ACE2) as a cellular entry receptor, which has triggered several therapeutic strategies against COVID-19 relying on the use of ACE2 recombinant proteins as decoy receptors. In this work, we propose an ACE2 silent Fc fusion protein (ACE2-hFcLALA) as a candidate therapy against COVID-19.

View Article and Find Full Text PDF

Background: The emergence of new SARS-CoV-2 variants poses a new challenge for the treatment of immunocompromised patients against COVID-19. In this context, high titer COVID-19 Convalescent Plasma (CCP) is one of the few available therapeutics for these patients. We have revisited the selection of CCP samples and its efficacy against Omicron XBB.

View Article and Find Full Text PDF

Background: Several variants of SARS-CoV-2 have a demonstrated impact on public health, including high and increased transmissibility, severity of infection, and immune escape. Therefore, this study aimed to determine the SARS-CoV-2 lineages and better characterize the dynamics of the pandemic during the different waves in Guinea.

Methods: Whole genome sequencing of 363 samples with PCR cycle threshold (Ct) values under thirty was undertaken between May 2020 and May 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!